Comparison of acebutolol and propranolol in essential hypertension.

[1]  M. Kendall,et al.  The penetration of acebutolol and its major metabolite, diacetolol, into human cerebrospinal fluid and saliva. , 1981, British journal of clinical pharmacology.

[2]  R. Watson,et al.  Comparison of once and twice daily administration of acebutolol in hypertension. , 1980, British journal of clinical pharmacology.

[3]  F. Messerli,et al.  Effects of beta blockade with acebutolol on hypertension, hemodynamics, and fluid volume , 1979, Clinical pharmacology and therapeutics.

[4]  A. Smith,et al.  Acebutolol in hypertension--double-blind trial against placebo. , 1978, British journal of clinical pharmacology.

[5]  C. Main,et al.  Antinuclear antibodies in patients receiving non-practolol beta-blockers. , 1978, British medical journal.

[6]  C. C. Pulliam,et al.  Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone. , 1976, The New England journal of medicine.

[7]  M. Pfisterer,et al.  Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. , 1975, The American journal of cardiology.

[8]  S. Lee,et al.  Drug-induced systemic lupus erythematosus: a critical review. , 1975, Seminars in arthritis and rheumatism.

[9]  D. Maxwell,et al.  β‐Adrenoceptor blocking properties and cardioselectivity of M & B 17,803A , 1973, British journal of pharmacology.

[10]  G. Humphreys,et al.  Ineffectiveness of propranolol in hypertensive Jamaicans. , 1968, British medical journal.

[11]  J. Wilson,et al.  NYSTAGMUS IN AN INFANT , 1927, British medical journal.

[12]  R G Shanks,et al.  Selective blockade of adrenoceptive beta receptors in the heart. , 1968, British journal of pharmacology and chemotherapy.